These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 22340660)

  • 1. Cryptosporidium enteritis in solid organ transplant recipients: multicenter retrospective evaluation of 10 cases reveals an association with elevated tacrolimus concentrations.
    Bonatti H; Barroso LF; Sawyer RG; Kotton CN; Sifri CD
    Transpl Infect Dis; 2012 Dec; 14(6):635-48. PubMed ID: 22340660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clostridium difficile-Associated Colitis Post-Transplant Is Not Associated with Elevation of Tacrolimus Concentrations.
    Bonatti HJR; Sadik KW; Krebs ED; Sifri CD; Pruett TL; Sawyer RG
    Surg Infect (Larchmt); 2017; 18(6):689-693. PubMed ID: 28650734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryptosporidium infection after renal transplantation in an endemic area.
    Bhadauria D; Goel A; Kaul A; Sharma RK; Gupta A; Ruhela V; Gupta A; Vardhan H; Prasad N
    Transpl Infect Dis; 2015 Feb; 17(1):48-55. PubMed ID: 25620388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and histological analysis of acute tacrolimus (TAC) nephrotoxicity in renal allografts.
    Shimizu T; Tanabe K; Tokumoto T; Ishikawa N; Shinmura H; Oshima T; Toma H; Yamaguchi Y
    Clin Transplant; 1999; 13 Suppl 1():48-53. PubMed ID: 10751057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of elevated tacrolimus trough levels in association with infectious enteritis on graft function in renal transplant recipients.
    Nakamura A; Amada N; Haga I; Tokodai K; Kashiwadate T
    Transplant Proc; 2014; 46(2):592-4. PubMed ID: 24656020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryptosporidiosis in children following solid organ transplantation.
    Krause I; Amir J; Cleper R; Dagan A; Behor J; Samra Z; Davidovits M
    Pediatr Infect Dis J; 2012 Nov; 31(11):1135-8. PubMed ID: 22810017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus as a risk factor for tuberculosis and outcome of treatment with rifampicin in solid organ transplant recipients.
    Ha YE; Joo EJ; Park SY; Wi YM; Kang CI; Chung DR; Joh JW; Lee SK; Song JH; Peck KR
    Transpl Infect Dis; 2012 Dec; 14(6):626-34. PubMed ID: 22372581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Clostridium difficile infection with outcomes of hospitalized solid organ transplant recipients: results from the 2009 Nationwide Inpatient Sample database.
    Pant C; Anderson MP; O'Connor JA; Marshall CM; Deshpande A; Sferra TJ
    Transpl Infect Dis; 2012 Oct; 14(5):540-7. PubMed ID: 22726461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and risks associated with Clostridium difficile-associated diarrhea after pediatric solid organ transplantation: a single-center retrospective review.
    Ciricillo J; Haslam D; Blum S; Kim MO; Liu C; Paulsen G; Courter J; Danziger-Isakov L
    Transpl Infect Dis; 2016 Oct; 18(5):706-713. PubMed ID: 27492796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing tacrolimus therapy in the maintenance of renal allografts: 12-month results.
    Bolin P; Shihab FS; Mulloy L; Henning AK; Gao J; Bartucci M; Holman J; First MR;
    Transplantation; 2008 Jul; 86(1):88-95. PubMed ID: 18622283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium difficile infection, a descriptive analysis of solid organ transplant recipients at a single center.
    Tsapepas DS; Martin ST; Miao J; Shah SA; Scheffert J; Fester K; Ma K; Lat A; Egan R; McKeen JT
    Diagn Microbiol Infect Dis; 2015 Apr; 81(4):299-304. PubMed ID: 25586932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New-onset diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression.
    Wagner K; Webber SA; Kurland G; Boyle GJ; Miller SA; Cipriani L; Griffith BP; Fricker FJ
    J Heart Lung Transplant; 1997 Mar; 16(3):275-82. PubMed ID: 9087870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors, clinical characteristics, and outcomes of invasive fungal infections in solid organ transplant recipients.
    Bodro M; Sabé N; Gomila A; Ayats J; Baliellas C; Roca J; Melilli E; Carratalà J
    Transplant Proc; 2012 Nov; 44(9):2682-5. PubMed ID: 23146493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of metronidazole use on tacrolimus concentrations in transplant patients treated for Clostridium difficile.
    Early CR; Park JM; Dorsch MP; Pogue KT; Hanigan SM
    Transpl Infect Dis; 2016 Oct; 18(5):714-720. PubMed ID: 27501504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus-induced elevation in plasma triglyceride concentrations after administration to renal transplant patients is partially due to a decrease in lipoprotein lipase activity and plasma concentrations.
    Tory R; Sachs-Barrable K; Goshko CB; Hill JS; Wasan KM
    Transplantation; 2009 Jul; 88(1):62-8. PubMed ID: 19584682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of anidulafungin in solid organ transplant recipients.
    Aguado JM; Varo E; Usetti P; Pozo JC; Moreno A; Catalán M; Len O; Blanes M; Solé A; Muñoz P; Montejo M;
    Liver Transpl; 2012 Jun; 18(6):680-5. PubMed ID: 22328277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A switch from conventional twice-daily tacrolimus to once-daily extended-release tacrolimus in stable kidney transplant recipients.
    Hatakeyama S; Fujita T; Yoneyama T; Yoneyama T; Koie T; Hashimoto Y; Saitoh H; Funyu T; Narumi S; Ohyama C
    Transplant Proc; 2012 Jan; 44(1):121-3. PubMed ID: 22310594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal function and cardiovascular risk profile after conversion from ciclosporin to tacrolimus: prospective study in 80 liver transplant recipients.
    Beckebaum S; Klein C; Varghese J; Sotiropoulos GC; Saner F; Schmitz K; Gerken G; Paul A; Cicinnati VR
    Aliment Pharmacol Ther; 2009 Oct; 30(8):834-42. PubMed ID: 19624550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of renal function improvement following tacrolimus conversion in cyclosporine-treated kidney transplant recipients.
    Chang HR; Lin CC; Lian JD
    Transplant Proc; 2007 Dec; 39(10):3135-41. PubMed ID: 18089339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten years of treatment with tacrolimus is related to an excellent renal function, allowing monotherapy in a large proportion of cases: unicentric results of the tacrolimus versus cyclosporine A European Multicentric Study in kidney transplant patients.
    Morales JM; Andrés A; Dominguez-Gil B; Arriola M; Gutiérrez MJ; Hernández E; Ortuño T; Praga M
    Transplant Proc; 2005 Nov; 37(9):3738-42. PubMed ID: 16386523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.